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Fifty one dichloromethane, ethyl acetate and ethanol extracts obtained from seven tree species used in Sudanese traditional medicine were
screened for in vitro anti-inflammatory activity using COX-1 and COX-2 assays and for antimycobacterial activity using the broth micro-dilution
methods against Mycobacterium aurum A+. In the cyclooxygenase assays, all ethyl acetate (leaf, bark, root) and ethanol root extracts of Acacia
seyal, ethyl acetate twig extracts of Capparis decidua, dichloromethane bark extracts of Combretum hartmannianum and ethanol bark extracts of
Ziziphus spina-christi showed inhibitory effect against prostaglandin synthesis by COX-2 ranging from 58 to 97% and weak (b50%) or no activity
against COX-1 induced prostaglandin production. In the antimycobacterial assays, ethanol extracts of A. seyal (bark), C. hartmannianum (leaf,
bark), Kigelia africana (bark) and Z. spina-christi (bark) inhibited growth of M. aurum A+ with MIC values ranging between 0.19 and 1.56 mg/
ml. The in vitro anti-inflammatory activity observed in this study support the utilization of these plants in Sudanese traditional medicine as crude
anti-inflammatory agents. The inhibition of COX-1 and COX-2 and the antimycobacterial effects of these plants have not been reported
previously. Isolation of bioactive compounds from A. seyal and Erythrina latissima are in progress in our laboratory.
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The use of traditional medicine is expanding globally. It
continues to be used not only for primary health care in de-
veloping countries, but also in countries where conventional
medicine is predominant in the national health care system
(World Health Organization, 2000). In vitro pharmacological
investigations of traditionally used medicinal plants offers an
incredible opportunity to explore and investigate a wide range
of plant-based drugs as a potential source of novel biologically
active agents and/or to validate claims made on their safety and
efficacy (Gautam et al., 2007).
Inflammation is a succession of changes which occurs in
living tissue when it is injured and/or is the reaction to injury of
living microcirculation and related tissues (Punchard et al.,
2004). Cyclooxygenase enzymes exist in two isoforms (COX-1⁎ Corresponding author.
E-mail address: rcpgd@ukzn.ac.za (J. Van Staden).
0254-6299/$ - see front matter © 2007 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2007.11.009and COX-2), coded by distinct genes on different chromosomes.
The two isoforms show about 50% homology and have similar
catalytic activity, but are physiologically distinct. COX-1 is
generally constitutive. It has housekeeping functions including
gastric cytoprotection and platelet aggregation. In contrast, COX-
2 is inducible in inflammatory cells. Though COX-2 can also be
constitutive in some tissues, its expression and activity is largely
responsive to adverse stimuli, such as inflammation (Pasinetti,
2001; Cronstein, 2002).
Tuberculosis continues to be an enormous global concern; it
is spreading and infects millions of people annually (Janin,
2007). Mycobacterium tuberculosis infection has recently been
increasing with a rising rate of coexisting human immunode-
ficiency virus (HIV). The search for new agents is needed due to
the emergence of drug resistant strains of mycobacterials
(Suksamrarn et al., 2003; Lee et al., 2006; Jiménez-Arellanes
et al., 2007).
Ongoing research in our laboratory has focused on investi-
gating the biological activities of some plants used in Sudanesets reserved.
226 I.M.S. Eldeen, J. Van Staden / South African Journal of Botany 74 (2008) 225–229traditional medicine. The reported uses for these Sudanese tra-
ditional plants are for the treatment of various ailments such
as infectious diseases, central nervous disorders and ailments
of an inflammatory nature (Iwu, 1993; Hutchings et al., 1996;
Neuwinger, 1996; El Ghazali et al., 1997). Acacia seyal Del.,
Erythrina latissima E.Mey, Capparis deciduas (Forssk.) Edgew.
and Combretum hartmannianum Schweinf. amongst others
showed good antimicrobial and anti-cholinesterase activities
during previous in vitro investigations, (Eldeen and Van Staden,
2007). In this report, anti-inflammatory and antimycobacterial
activities of extracts obtained from some trees used in Sudanese
traditional medicine are highlighted.
2. Materials and methods
2.1. Plant material
Plant materials (leaves and/or twigs, roots, bark) were
collected from Shambat, Khartoum north-Sudan in December
2005. The plants were authenticated at the Department of
Silviculture, Faculty of Forestry, University of Khartoum,
Sudan and voucher specimens deposited in the Herbarium
(Table 1). Botanical names, voucher specimen numbers and
summary of traditional uses of the investigated plant species are
recorded in Table 1.
The collected materials were dried in an oven at 50 °C for
five days, powdered and extracted sequentially using dichlor-
omethane, ethyl acetate and ethanol (10 mg/ml) by sonication
for 1 h. The extracts were filtered using Whatman No.1 filter
paper and dried under a fan at room temperature.
2.2. Anti-inflammatory activity of the plant extracts using the
cyclooxygenase assays
2.2.1. Cyclooxygenase assays (COX-1 and COX-2)
Anti-inflammatory activity of the plant extracts was de-
termined using both the COX-1 and COX-2 assays. The basic
protocol is the same for both assays, allowing a comparison
of the inhibitory effects of the extracts on the two enzymes.Table 1
Plant name/authority, family, voucher number, traditional uses and references of tre
Plant name Family Voucher Traditional uses in Sudan
Acacia seyal Del. Mimosaceae Ibra1 Arthritis rheumatism and r
Balanites aegyptiaca
(L.) Del.
Balanitaceae Ibra2 Venereal diseases, rheuma
1997; Van Wyk et al., 199
Capparis decidua
(Forssk.) Edgew.
Capparidaceae Ibra3 Jaundice, rheumatic arthrit
Combretum
hartmannianum Schweinf.
Combretaceae Ibra4 Arthritis rheumatism, skin
El Ghazali et al., 1997).
Erythrina latissima E.Mey. Papilionaceae Ibra5 Bronchial infections, coug
et al., 1996; Van Wyk et a
Kigelia africana
(Lam.) Benth.
Bignoniaceae Ibra6 Stomach problem, cough,
Ziziphus spina-christi
(L.) Willd.
Rhamnaceae Ibra7 Ulcers and gonorrhea, sore
El Ghazali et al., 1997; DaThe COX-1 bioassay was performed according to the method
described by Jäger et al. (1996). The COX-1 enzyme (isolated
from ram seminal vesicles) (Sigma-Aldrich) was activated with
co-factor solution and pre-incubated on ice for 5 min. Sixty µl
of this enzyme/co-factor solution were added to 20 µl of test
solution (2.5 µl of the plant extract +17.5 µl water) and pre-
incubated for 5 min at room temperature. Twenty µl of [14C]
arachidonic acid were added to the test samples and incubated at
37 °C for 10 min. After incubation, the reaction was terminated
by adding 10 µl 2 N HCl. Four µl of a 0.2 mg/ml carrier solution
of unlabelled prostaglandins were added. Prostaglandins were
separated from the unmetabolised arachidonic acid by silica
gel column chromatography. The samples were loaded onto
individual Pasteur pipettes packed with silica gel (particle
size 0.063–0.200 mm, Merck). Four ml of hexane:dioxane:
acetic acid (350:150:1 v/v) mixture were added, 1 ml at a time,
to the column to elute the arachidonic acid. The prostaglandins
were then eluted by the addition of 3 ml ethyl acetate:methanol
(425:75 v/v) mixture and received in scintillation vials
individually. Four ml scintillation solution were added to each
vial containing the prostaglandins and radioactivity was mea-
sured using a Beckman L S 6000LL scintillation counter.
The COX-2 assay described by Noreen et al. (1998) with
slight modifications (Zschocke and Van Staden, 2000) was
followed. Human recombinant COX-2 containing a six histidine
sequence near the N-terminus isolated from a Baculovirus over
expression system in Sƒ 21 cells was used (Sigma-Aldrich). The
same protocol as for COX-1 was followed except that in the
preparation of co-factor solution where 0.3 and 0.6 mg adrena-
line was used with COX-1 and COX-2, respectively. In each test
assay, four controls were run. Twowere background in which the
enzyme was inactivated with HCl before the addition of [14C]
arachidonic acid, and two were solvent blanks. Indomethacin
was included in each test assay as a standard (5 µM for the COX-
1 assay and 200 µM for the COX-2 assay). Both assays were
performed in duplicate with double determinations for each
sample per assay. Percentage inhibition by the tested compound
was calculated by comparing the amount of radioactivity present
in the sample to that in the solvent blank.e species used in Sudanese traditional medicine
and other African countries
heumatic fever (El Ghazali et al., 1997).
tism, digestion problems, dysentery and bilharzias (Iwu, 1993; El Ghazali et al.,
7).
is and to treat swells (El Ghazali et al., 1997).
dryness, jaundice and bacterial diseases (Iwu,1993; Neuwinger, 1996;
hs, wounds, abscesses, arthritis and throat inflammation (Iwu,1993; Hutchings
l., 1997).
dysentery and venereal diseases (Neuwinger, 1996; El Ghazali et al., 1997).
throat, chest pain, dysentery, venereal diseases and wounds (Neuwinger, 1996;
fni et al., 2005).
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strain of Mycobacterium aurum A+
2.3.1. Media and growth conditions
Middlebrook 7H10 agar base (ref 453982) and Middlebrook
7H9 broth base (ref 454012) were used. The supplement OADC
(oleic acid+albumin+dextrose+catalase) (Remel, USA) was
added (10%) to both agar and broth media. A stock culture of
Mycobacterium aurum A+ was obtained from the Microbiology
Laboratory, Division of Pharmacology, University of Cape
Town. The bacterium was first isolated from human sputum
in France in 1965 (Tsukamura, 1966). The organism (stock
number CIP 104482) was used as indicated in the Standard
Operating Procedures (SOP no. GL2005/01) for determination
of minimum inhibitory concentration (MIC) of M. aurum as
used in Microbiology Laboratory, Cape Town. Two (5 ml)
supplemented 7H9 broths (Middlebrook 7H9+10% OADC)
were inoculated by the stock bacterial culture and grown for
72 h at 37 °C. Gram and Ziel–Neelson stains were performed on
these cultures to ensure culture purity. Twenty percent sterile
glycerol was added to each culture and 500 µl aliquots were
made into sterile 1.5 ml Eppendorf tubes. These stocks
represent G0 stocks and were stored at −70 °C. A single
stock was used to inoculate two further broth cultures. Further
glycerol stocks were prepared from these cultures as described
above and stored at −70 °C, representing G1 stocks. A single
G1 stock was used to inoculate two supplemented Middlebrook
7H10 agar (7H10+10% OADC) plates and incubated at 37 °C
for 4 days. From this culture a single colony was used to
inoculate 5 ml supplemented 7H9 broth. This was grown at
37 °C for 72 h and used for the experiment.
2.3.2. Broth micro-dilution method
The broth microdilution method (Swenson et al., 1982)
was used to determine the minimum inhibitory concentra-
tion (MIC) of M. aurum A+ of the investigated plant extracts
using 96-well microtiter plates. The extracts were dissolved
in water:ethanol (1:1 v/v). One hundred microliter of the
supplemented 7H9 broth were added to each well using a multi-
channel pipette. A further 100 µl of supplemented 7H9 broth were
added to all the wells of the first column to serve as a medium
control and blank. For the drug and solvent controls, as well as the
test samples, 100 µl of the respective sample were added to the
first well of the column.Amulti-channel pipette was used tomake
a two fold serial dilution startingwith a concentration of 25mg/ml
of the extracts and 62.5 µg/ml of the ciprofloxacin (standard drug
control). The optical density (OD) of the 72 h liquid culture was
adjusted to 0.125 at 550 nm. One hundredmicroliter of the diluted
culture were added to every well of the microtitre plate excluding
the wells of the first column that served as the medium control.
The plates were loosely sealed in plastic bags to prevent them
drying out and incubated at 37 °C for 72 h.After incubation, 40µ1
of 0.4 mg/ml solution of p-iodonitrotetrazolim salt (INT) were
added to each well of the plate. The plates were left sealed in
plastic packets overnight at 37 °C. The lowest concentration
containing no indication of red colour as a result of INT was
deemed to be the MIC.3. Results
3.1. Inhibition of cyclooxygenase enzyme activity
Inhibition of cyclooxygenase (COX-1 and COX-2) enzyme
activity by the plant extracts was recorded as percentage
inhibition of prostaglandin biosynthesis. Results expressed as
mean±S.D are shown in Table 2. A minimum inhibition of 50%
is required for plant extracts to be considered active. All ethyl
acetate (leaf, bark, root) and ethanol root extracts of A. seyal,
ethyl acetate twig extracts of C. decidua, dichloromethane bark
extract of C. hartmannianum and ethanol bark extracts of Zi-
ziphus spina-christi showed good activity against COX-2
(inhibition (%) of prostaglandins ranging from 58 to 97%)
and weak or no activity against COX-1 (inhibition (%) of
prostaglandins b50%). Extracts from Kigelia africana (excep-
tions were leaf ethanol and bark dichloromethane extracts)
showed only activity against COX-1. E. latissima (dichlor-
omethane and ethanol bark and root extracts), Z. spina-christi
(dichloromethane and ethyl acetate leaf and bark extracts), A.
seyal (ethanol leaf and bark extracts), Balanites aegyptiaca
(dichloromethane bark extract) possessed activity against both
COX-1 and COX-2. With the exception of K. africana and Z.
spina-christi, all ethyl acetate extracts showed no activity
against COX-1.
3.2. Antimycobacterial activity of the tested plant extracts as
detected against Mycobacterium aurum A+
A strain of the rapidly growing, non-pathogenicM. aurumA+
was used in this study due to the slow growth rate and the highly
infectious nature of M. tuberculosis. Inhibition of M. aurum A+
growth is highly predictive of activity against M. tuberculosis
(Chung et al., 1995).
The minimum inhibitory concentrations (MIC) of the plant
extracts against M. aurum A+ as determined using the broth
micro-dilution method are shown in Table 2. Ethanol extracts of
A. seyal (bark), C. hartmannianum (leaf and bark), K. africana
(bark) and Z. spina-christi (bark) inhibited growth of M. aurum
with MIC values ranging from 0.19 and 1.5 mg/ml. Dichlor-
omethane and ethyl acetate extracts showed weak activity
against M. aurum in this study. Exceptions were C. hartman-
nianum (dichloromethane leaf extract) and E. latissima
(dichloromethane root and bark and ethyl acetate bark extracts).
4. Discussion and conclusions
A. seyal is used traditionally in Sudan as a cure for colds,
jaundice, headache and burns (Sahni, 1968). Women in Sudan
use bark and wood of A. seyal and Combretum species for
making a so-called smoke bath. Exposure to the smoke bath is
believed to relieve rheumatic pains, smooth skin and achieve
general body relaxation (Ogbazghi and Bein, 2006). Exposure to
the smoke bath from wood of A. seyal is also used widely
in Sudan (not documented) to accelerate recovery from an
episiotomy cuts and/or tears in the cases of operative vaginal
deliveries (Macleod and Murphy, In press), beside other
Table 2
Inhibition (%) of prostaglandin synthesis and minimum inhibitory concentration (MIC) values againstMycobacterium aurumA+ by plant extracts obtained from trees




COX-1 inhibition (%) COX-2 inhibition (%) MIC values (mg/ml)














Acacia seyal Leaf 55±3.1 40±1.9 69±3.1 84±2.9 89±2.9 90±2.7 12.5 25 3.12
Bark 74±3.0 12±1.7 68±5.5 39±3.1 96±4.6 96±1.3 25 25 0.78
Root 96±2.8 46±2.6 45±5.2 67±2.6 94±3.8 97±5.5 12.5 12.5 3.12
Balanites aegyptiaca Leaf 40±3.0 42±3.9 76±2.4 90±1.1 88±1.5 50±3.3 12.5 na 3.12
Bark 77±5.1 09±3.6 91±1.7 72±4.4 76±4.9 52±1.3 12.5 na 12.5
Root 97±4.0 07±3.0 98±1.5 28±2.3 48±3.8 48±4.9 25 12.5 12.5
Capparis decidua Twigs 58±3.4 03±1.3 52±2.2 79±3.4 81±1.4 58±4.0 12.5 25 6.25
Root 77±5.9 26±2.7 98±2.1 60±3.9 22±3.4 36±2.9 25 na 6.25
Combretum
hartmannianum
Leaf 94±1.9 05±2.1 62±1.6 66±2.7 90±5.1 52±3.6 0.78 3.12 0.19
Bark 10±2.1 19±2.9 57±2.6 90±1.5 34±3.8 41±2.9 12.5 25 1.56
Root 48±1.2 34±3.1 42±3.1 20±4.0 29±2.1 39±2.4 3.12 na 12.5
Erythrina latissima Bark 97±2.3 31±2.4 54±1.6 81±2.0 82±0.9 53±1.6 1.56 1.56 0.39
Root 96±2.2 48±3.1 77±2.6 74±2.2 76±2.1 57±1.0 0.39 12.5 6.25
Kigelia africana Leaf 72±2.9 91±3.5 42±4.4 22±5.2 16±2.9 19±4.3 6.25 12.5 6.25
Bark 87±3.1 98±1.0 67±0.9 60±3.3 24±4.4 29±1.5 3.12 12.5 1.56
Ziziphus spina-christi Leaf 83±3.4 96±2.8 04±2.2 84±2.5 84±4.1 51±1.0 12.5 12.5 6.25
Bark 66±2.1 97±1.1 0.3± 1.1 79±1.9 88±1.2 58±2.4 25 6.25 0.39
Inhibition of prostaglandin and the MIC values were determined using the cyclooxygenase (COX-1 and COX-2) assays and the broth micro-dilution method
respectively.
Inhibition obtained (%) is expressed as mean±S.D. Percentage Inhibition of prostaglandin synthesis by indomethacin (standard) was 80±1.9% for COX-1 and 69±
2.4% for COX-2. na = not active at the highest concentration tested (25 mg/ml). Minimum inhibitory concentration (MIC) of ciprofloxacin (standard) against
M. aurum in this study was 2 µg/ml.
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2006). Some of these symptoms are treated clinically by anti-
inflammatory drugs (Lewis and Elvin-Lewis, 2003). Anti-
inflammatory activity showed by these plants supports their
traditional uses in Sudanese traditional medicine. Our findings
also support the traditional uses and the reported anti-
inflammatory activity of C. decidua (Ageel et al., 1986). Several
chemical compounds were previously isolated from the
investigated plant species. Capparisine, capparisinine and L-
stachydrine and isocodonocarpine isolated from C. deciduas
(Ageel et al., 1986), quercetin, quercetin-3-ο-[β-xylosyl-(1-2)-
α-rhamnoside]4′-о-α-rhamnoside were isolated from Z. spina-
christi (Shahat et al., 2001). E. latissimawas reported to produce
erythrina-type alkaloids such as (+)erythraline, (+)-11-hydro-
xyerysodine, (+)-erythratidine and (+)-erysosalvine (Majinda
et al., 2001). Norviburtinal, octacosanol, kigelin and stigmas-
terol amongst others occur in K. africana (Neuwinger, 1996).
Inhibition of cyclooxygenase enzyme activity and/or antimyco-
bacterial effects showed by the plant extracts in this studymay be
due to the presence of one ormore of these chemical compounds.
Tannin is a general descriptive name for a group of polymeric
phenolic substances (Cowan, 1999). They affect highly purified
enzyme-based targets due to their ability to bind strongly with
proteins (Cowan, 1999). This may, in the case of anti-
inflammatory testing, lead to the inhibition of prostaglandin
synthesis through blocking the cyclooxygenase enzymes.
The mode of antimicrobial action of tannins may also be
related to their ability to inactivate microbial adhesions, en-
zymes and cell envelope (Cowan, 1999). Tannins therefore, maybe responsible, in part, for some of the anti-inflammatory and/
or antimycobacterial activities showed by some of the plant
extracts investigated in this study.
Inhibition of COX-1, as mentioned earlier, may lead to
adverse effects on the gastrointestinal mucosa which may cause
gastric ulceration and increase the risk of adverse cardiovascular
events. However, some authors also reported that COX-2 is
constitutively expressed in some tissues (Cronstein, 2002). This
suggests that prostaglandins produced by COX-2 play an
important role in the biological and/or physiological functions
of such tissues (Cronstein, 2002). As some of the investigated
plant extracts showed activity against COX-1 or both COX-1
and COX-2 in this study, the use of these plants as traditional
anti-inflammation agents should be carefully monitored.
In a previous investigation, 75% of the currently investigated
plant extracts showed antibacterial activity with MIC values less
than/or around 1.5 mg/ml against Bacillus subtilis, Staphylo-
coccus aureus (Gram-positive), Escherichia coli and Klebsiella
pneumoniae (Gram-negative) (Eldeen and Van Staden, 2007).
However, in this study only 19% of the same plant extracts
showed activity againstM. aurum A+ with MIC value less than/
or around 1.5 mg/ml. Poor activity shown by some of the plant
extracts may, in part, be due to a lack of uptake by Mycobac-
terium species due to the complex lipoglycan on the cell surface
which provide a strong physical barrier to intracellular-acting
agents (Oliva et al., 1998; Ballell et al., 2005). In contrast, some
extracts (ethanol bark extract of E. latissima and leaf extract of
C. hartmannianum) showed both antibacterial (Eldeen and Van
Staden, 2007) and antimycobacterial activities in the present
229I.M.S. Eldeen, J. Van Staden / South African Journal of Botany 74 (2008) 225–229study. This may be due to the presence of bioactive agents in
these extracts that inhibit bacterial protein synthesis and could
therefore be expected to exhibit antimicrobial activity against a
range of bacteria including mycobacteria (Oliva et al., 1998).
However, the mechanism of action of many of antimycobacter-
ial drugs is poorly understood (Oliva et al., 1998; Janin, 2007).
Anti-inflammatory and antimycobacterial activity observed
by some of the investigated plant extracts in this study indicate
the presence of bioactive agents that warrant further investiga-
tion. Ongoing research in our laboratory is currently focused on
the isolation and identification of bioactive compounds from A.
seyal, C. decidua, E. latissima and Z. spina-christi.
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